Ledisept-Pharmex pessaries 16 mg No. 10

Translation of the instructions can be

Instruction

For medical use of the medicinal product

Ladysept-Pharmex

(Ledisept-pharmex)

Composition:

Active ingredient: chlorhexidine;

1 pessary contains chlorhexidine bigluconate, 20% solution, equivalent to chlorhexidine 16 mg;

excipient: polyethylene oxide.

Dosage form.

Pessaries.

Main physical and chemical properties: pessaries are white to white with a yellowish tint, the surface may be marbled. A funnel-shaped depression and an air core may be present.

Pharmacotherapeutic group.

Antimicrobial and antiseptic agents used in gynecology. ATS code g01a x.

Pharmacological properties.

Pharmacodynamics.

Chlorhexidine bigluconate has a rapid and pronounced effect on gram-positive and gram-negative bacteria, yeasts and dermatophytes: Treponema pallidum, Chlamidia spp., Ureaplasma spp., Neisseria gonоrrhоeae, Trichomonas vaginalis. Some strains of Pseudomonas spp., Proteus spp. are weakly sensitive to the drug. Acid-resistant forms of bacteria, bacterial spores, fungi, viruses are insensitive to the drug.

Pharmacokinetics.

When used intravaginally, it is practically not absorbed and has no systemic effect.

Clinical characteristics.

Indication.

Prevention of sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis, chlamydia, ureaplasmosis) and infectious-inflammatory complications in obstetrics and gynecology (before surgical treatment of gynecological diseases, before childbirth and abortion, before and after installation of an intrauterine device, before and after diathermocoagulation of the cervix, before intrauterine examinations).

Treatment of bacterial vaginosis, colpitis, cervical erosion.

Contraindication.

Individual hypersensitivity to the components of the drug.

Interaction with other drugs and other types of interactions.

Chlorhexidine bigluconate cannot be used together with detergents containing an anionic group (saponins, sodium lauryl sulfate, sodium carboxymethylcellulose), as well as with soap.

Application features.

Use during pregnancy or breastfeeding.

Not contraindicated.

The ability to influence the reaction speed when driving vehicles or other mechanisms.

Does not affect.

Method of administration and doses.

The drug is to be used intravaginally. Before use, the pessary should be removed from the contour packaging.

Treatment: apply 1 pessary 2 times a day for 7-10 days, depending on the nature of the disease. If necessary, the course of treatment may be extended to 20 days.

Prevention of sexually transmitted diseases: use 1 pessary once no later than 2 hours after sexual intercourse.

Pregnancy. Given the severity of the infectious process, bacteriological research data, the presence of a threat of termination of pregnancy, chlorhexidine bigluconate should be used 1 pessary 1 or 2 times a day as monotherapy or as part of complex therapy. Duration of use - from 5 to 10 days.

When breastfeeding, the drug should be used in the usual recommended doses.

Children.

There is no experience of use.

Overdose.

Overdose and toxic effects when using the drug have not been identified.

Adverse reactions.

Allergic reactions and itching at the site of suppository insertion are possible.

Expiration date.

3 years.

Storage conditions.

Store in original packaging at a temperature not exceeding 25 degrees Celsius. Keep out of the reach of children.

Packaging.

For 5 pessaries in a Strip, 2 strips in a pack.

Vacation category.

Without a prescription.

Producer.

"Pharmex Group" LLC.

Location of production and its address of place of business.

Ukraine, 08301, Kyiv region, Boryspil city, Shevchenko st., 100.

All cases of adverse reactions must be reported to the manufacturer:

LLC "PHARMEX GROUP", Ukraine, 08301, Kyiv region, Boryspil city, Shevchenko st., 100, tel.: +38 (044) 391-19-19, fax: +38 (044) 391-19-18, or via the form on the website: http://www.pharmex.com.ua / contacts / farmakonadzor